Toni Choueiri: Extremely well-deserved honor for Eli Van Allen on his Chair
Toni Choueiri shared a post about Eli Van Allen. Read his post on X below:
“Massive congratulations and extremely well-deserved honor for our own Dana-Farber Cancer Institute’s Eli Van Allen on his Chair!
Eli leads our large Dana-Farber Division of Population Sciences and is part of the Dana-Farber Lank Center for Genitourinary Oncology as a GU Oncologist!”
More posts featuring Toni Choueiri.
Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School.
As a medical oncologist, clinical trialist, and translational researcher, he specializes in treating genitourinary cancers (prostate, bladder, testis, and kidney cancer), with a focus on kidney cancer.
Eliezer (Eli) Van Allen is an Associate Professor of Medicine at Harvard Medical School and Chief of the Division of Population Sciences at the Dana-Farber Cancer Institute. He is also an Institute Member at the Broad Institute and a Member Researcher at The Parker Institute for Cancer Immunotherapy.
As a medical oncologist and computational biologist, he develops algorithms to analyze high-dimensional data from cancer patients to address key challenges in the field.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023